News
FDA clears Ionis drug as first therapy for rare disease FCS
Ionis Pharma's Tryngolza (olezarsen) has become the first FDA-approved drug therapy for adults with rare disease familial chylomicronaemia syndrome.
News
Lilly grabs first-ever FDA nod for a sleep apnoea drug
Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea, which affects millions in the US.
News
Mesoblast finally pushes GvHD cell therapy over finish line
At its third attempt, Mesoblast has secured FDA approval for the first-ever mesenchymal stem cell (MSC) therapy, Ryoncil for acute GvHD in children.
News
Lilly's Alzheimer's drug Kisunla is cleared in China
Eli Lilly has another approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest drugs market.
News
MSD eyes June verdict for paediatric RSV antibody
The FDA has started a review of MSD's RSV antibody clesrovimab, a potential rival to Beyfortus, with a verdict due in the middle of next year.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
